Analyst Coverage Initiated: EMBC rating Underperform by BofA Securities
Price Target: $25
Report Date: 06-21-2022
Symbol: EMBC - Embecta Corp.
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Analyst Coverage Initiated: EMBC rating Underperform by BofA Securities
Price Target: $25
Embecta Corp. (EMBC)
300 Kimball Drive
Parsippany, NJ 07054
Phone: 201-847-6880
Website: https://www.embecta.com
CEO:
NASDAQ, NASDAQ Global Select
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey.
best stock trading signals, stock market trading signals, weekly options trading signals, stock trading signals services
Good stock signals have been found on this server. That is all we know.
+1 (407) 559-7228